Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,219 public trials 1,011 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer

NCT00216203

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Medical & Surgical Specialists, LLC Galesburg, Illinois, United States
  • Cancer Care Center of Southern Indiana Bloomington, Indiana, United States
  • Elkhart Clinic Elkhart, Indiana, United States
  • Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States
View Trial Details
Completed

A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors

NCT01457417

Conditions
Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
Locations
  • Scottsdale Healthcare Scottsdale, Arizona, United States
  • New York Oncology Hematology, P.C. Albany, New York, United States
  • Greenville Hospital System University Medical Center Greenville, South Carolina, United States
  • Texas Oncology - Baylor, Charles A. Sammonds Cancer Center Dallas, Texas, United States
View Trial Details
Completed

Detecting EGFR T790M Mutations From Circulating Tumor Cells

NCT01734915

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

NCT00144989

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi-ken, Japan
  • Aichi Cancer Center,Aichi Hospital Okazaki,Kake-machi,Kuriyado,18, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi,Kashiwanoha,6-5-1, Chiba, Japan
  • National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan
View all 37 locations
View Trial Details
Completed

Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC

NCT00824408

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1230.5.00104 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada
  • 1230.5.00114 Boehringer Ingelheim Investigational Site Kelowna, British Columbia, Canada
  • 1230.5.00109 Boehringer Ingelheim Investigational Site Surrey, British Columbia, Canada
  • 1230.5.00107 Boehringer Ingelheim Investigational Site Vancouver, British Columbia, Canada
View Trial Details
Completed

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

NCT00035152

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Little Rock Hematology/Oncology Associates Little Rock, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Medical Oncology Care Associates Orange, California, United States
View all 56 locations
View Trial Details
Completed

LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations

NCT00525148

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1200.22.28 Boehringer Ingelheim Investigational Site Bakersfield, California, United States
  • 1200.22.32 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
  • 1200.22.4 Boehringer Ingelheim Investigational Site Mission Hills, California, United States
  • 1200.22.16 Boehringer Ingelheim Investigational Site Orange, California, United States
View all 30 locations
View Trial Details

Related conditions